secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2022-01-04T23:59:59+00:00
Accession:  0000950170-22-000038
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight appoints Shweta Maniar and Dr. Tamara Fountain to board; expands to nine members
--------------------------------------------------------------------------------

- Board expanded from 7 to 9; Maniar (Google Cloud) and Dr. Fountain (ophthalmologist) effective Dec 31, 2021 and Jan 1, 2022.
- Maniar serves on Governance/Nominating Committee; receives $45k annual retainer, $5k committee fee, initial RSUs valued at $217,500.
- Dr. Fountain, 2021 President of American Academy of Ophthalmology, serves on Audit Committee; receives no compensation during 2022 per AAO policy.
- Outside Director Compensation Policy updated: annual cash retainer raised from $40k to $45k; initial RSU award increased from $125k to $217,500.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000095017022000038/0000950170-22-000038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000095017022000038/rxst-20211229.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-000038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer